162 related articles for article (PubMed ID: 16918994)
21. Interleukin-6 promotes tumorigenesis by altering DNA methylation in oral cancer cells.
Gasche JA; Hoffmann J; Boland CR; Goel A
Int J Cancer; 2011 Sep; 129(5):1053-63. PubMed ID: 21710491
[TBL] [Abstract][Full Text] [Related]
22. Aberrant methylation impairs low density lipoprotein receptor-related protein 1B tumor suppressor function in gastric cancer.
Lu YJ; Wu CS; Li HP; Liu HP; Lu CY; Leu YW; Wang CS; Chen LC; Lin KH; Chang YS
Genes Chromosomes Cancer; 2010 May; 49(5):412-24. PubMed ID: 20095042
[TBL] [Abstract][Full Text] [Related]
23. Epigenetic mediated silencing of EYA4 contributes to tumorigenesis in oral dysplastic cells.
Towle R; Truong D; Garnis C
Genes Chromosomes Cancer; 2016 Jul; 55(7):568-76. PubMed ID: 27015871
[TBL] [Abstract][Full Text] [Related]
24. Epigenetic regulation of the X-linked tumour suppressors BEX1 and LDOC1 in oral squamous cell carcinoma.
Lee CH; Wong TS; Chan JY; Lu SC; Lin P; Cheng AJ; Chen YJ; Chang JS; Hsiao SH; Leu YW; Li CI; Hsiao JR; Chang JY
J Pathol; 2013 Jul; 230(3):298-309. PubMed ID: 23362108
[TBL] [Abstract][Full Text] [Related]
25. Status of reduced expression and hypermethylation of the APC tumor suppressor gene in human oral squamous cell carcinoma.
Uesugi H; Uzawa K; Kawasaki K; Shimada K; Moriya T; Tada A; Shiiba M; Tanzawa H
Int J Mol Med; 2005 Apr; 15(4):597-602. PubMed ID: 15754020
[TBL] [Abstract][Full Text] [Related]
26. Promoter Methylation of Cancer Stem Cell Surface Markers as an Epigenetic Biomarker for Prognosis of Oral Squamous Cell Carcinoma.
Han YK; Park HY; Park SG; Hwang JJ; Park HR; Yi JM
Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36498950
[TBL] [Abstract][Full Text] [Related]
27. Identification of GPX3 epigenetically silenced by CpG methylation in human esophageal squamous cell carcinoma.
He Y; Wang Y; Li P; Zhu S; Wang J; Zhang S
Dig Dis Sci; 2011 Mar; 56(3):681-8. PubMed ID: 20725785
[TBL] [Abstract][Full Text] [Related]
28. Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer.
Kozaki K; Imoto I; Mogi S; Omura K; Inazawa J
Cancer Res; 2008 Apr; 68(7):2094-105. PubMed ID: 18381414
[TBL] [Abstract][Full Text] [Related]
29. DNA methylation in oral squamous cell carcinoma: molecular mechanisms and clinical implications.
González-Ramírez I; García-Cuellar C; Sánchez-Pérez Y; Granados-García M
Oral Dis; 2011 Nov; 17(8):771-8. PubMed ID: 21781230
[TBL] [Abstract][Full Text] [Related]
30. Methylation-associated gene silencing of RARB in areca carcinogens induced mouse oral squamous cell carcinoma.
Lai ZL; Tsou YA; Fan SR; Tsai MH; Chen HL; Chang NW; Cheng JC; Chen CM
Biomed Res Int; 2014; 2014():378358. PubMed ID: 25197641
[TBL] [Abstract][Full Text] [Related]
31. Genomic loss and epigenetic silencing of very-low-density lipoprotein receptor involved in gastric carcinogenesis.
Takada H; Imoto I; Tsuda H; Nakanishi Y; Sakakura C; Mitsufuji S; Hirohashi S; Inazawa J
Oncogene; 2006 Oct; 25(49):6554-62. PubMed ID: 16715143
[TBL] [Abstract][Full Text] [Related]
32. Epigenetic Deregulation of Protein Tyrosine Kinase 6 Promotes Carcinogenesis of Oral Squamous Cell Carcinoma.
Hsieh YP; Chen KC; Chen MY; Huang LY; Su AY; Chiang WF; Huang WT; Huang TT
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35562900
[TBL] [Abstract][Full Text] [Related]
33. Re-expression of Lactotransferrin, a candidate tumor suppressor inactivated by promoter hypermethylation, impairs the malignance of oral squamous cell carcinoma cells.
Zhang J; Ling T; Wu H; Wang K
J Oral Pathol Med; 2015 Sep; 44(8):578-84. PubMed ID: 25370482
[TBL] [Abstract][Full Text] [Related]
34. Epigenetic inactivation of RASSF2 in oral squamous cell carcinoma.
Imai T; Toyota M; Suzuki H; Akino K; Ogi K; Sogabe Y; Kashima L; Maruyama R; Nojima M; Mita H; Sasaki Y; Itoh F; Imai K; Shinomura Y; Hiratsuka H; Tokino T
Cancer Sci; 2008 May; 99(5):958-66. PubMed ID: 18294275
[TBL] [Abstract][Full Text] [Related]
35. Expression of NANOG and Its Regulation in Oral Squamous Cell Carcinoma.
Grubelnik G; Boštjančič E; Grošelj A; Zidar N
Biomed Res Int; 2020; 2020():8573793. PubMed ID: 32733958
[TBL] [Abstract][Full Text] [Related]
36. HOP/OB1/NECC1 promoter DNA is frequently hypermethylated and involved in tumorigenic ability in esophageal squamous cell carcinoma.
Yamashita K; Kim MS; Park HL; Tokumaru Y; Osada M; Inoue H; Mori M; Sidransky D
Mol Cancer Res; 2008 Jan; 6(1):31-41. PubMed ID: 18234960
[TBL] [Abstract][Full Text] [Related]
37. [Expression of large tumor suppressor homolog 2 gene and its promotor methylation in oral squamous cell carcinoma].
Yue ZW; Liu JZ
Zhonghua Kou Qiang Yi Xue Za Zhi; 2017 Sep; 52(9):569-573. PubMed ID: 29972924
[No Abstract] [Full Text] [Related]
38. WIF1 is a frequent target for epigenetic silencing in squamous cell carcinoma of the cervix.
Delmas AL; Riggs BM; Pardo CE; Dyer LM; Darst RP; Izumchenko EG; Monroe M; Hakam A; Kladde MP; Siegel EM; Brown KD
Carcinogenesis; 2011 Nov; 32(11):1625-33. PubMed ID: 21873353
[TBL] [Abstract][Full Text] [Related]
39. Promoter methylation regulates cadherin switching in squamous cell carcinoma.
Chen Q; Lipkina G; Song Q; Kramer RH
Biochem Biophys Res Commun; 2004 Mar; 315(4):850-6. PubMed ID: 14985090
[TBL] [Abstract][Full Text] [Related]
40. PTEN expression and methylation status in oral squamous cell carcinoma.
Kurasawa Y; Shiiba M; Nakamura M; Fushimi K; Ishigami T; Bukawa H; Yokoe H; Uzawa K; Tanzawa H
Oncol Rep; 2008 Jun; 19(6):1429-34. PubMed ID: 18497947
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
